期刊文献+

产超广谱β-内酰胺酶肺炎克雷伯菌院内肺部感染25例临床分析 被引量:1

RETROSPECTIVE STUDY ON 25 PATIENTS WITH NOSOCOMIAL PULMONARY INFECTION CAUSED BY ESBLS PRODUCING KLEBSIELLA PNEUMONIAE
在线阅读 下载PDF
导出
摘要 目的探讨产超广谱β-内酰胺酶(ESBLs)肺炎克雷伯菌院内肺部感染发生的危险因素及预后相关因素。方法对25例产ESBLs肺炎克雷伯菌院内肺部感染患者的临床资料作回顾性分析。结果本组25例病人在产ESBLs肺炎克雷伯菌分离前均使用过第三代头孢菌素,除1例外均合并有基础疾病。其中单独感染5例,混合感染20例,以混合一到二种病原菌为多,病原菌种类以真菌为主。无论是否混合感染,治疗产ESBLs肺炎克雷伯菌感染的住院时间均较长。混合感染的死亡率比单独感染要高且死亡率随着混合感染病原菌种类的增加而增高。产ESBLs肺炎克雷伯菌感染时,白细胞数量多者、年龄小者预后好。结论存在严重基础疾病且有应用第三代头孢菌素史的病人,要密切注意是否有产ESBLs肺炎克雷伯菌院内肺部感染。当存在产ESBLs肺炎克雷伯菌感染时,患者年龄、白细胞数、是否混合感染及其病原菌的种类就成为判断患者预后的重要相关因素。 Objective To analyze the risk factors and prognosis related factors of nosocomial pulmonary infection caused by ESBLs producing Klehsiella pneumoniae. Methods To review and analyze the clinical data of 25 nosocomial pulmonary infected patients eaused by ESBLs producing Klehsiella pneumoniae, Results Total of 25 patients had been treated by the third generation cephalosporin before KSBLs producing Klehsiella pneumoniae were isolated. 24 of them had basic disease. 5 of them were infected only by the ESBLs producing Klebsiells pneumoniae while the other 20 were mixed infection. There were one, two or three types of pathogens in one mixed infected patient. The most common pathogen was fungi. The length of stay was lunger if one was infected by such bacteria. The mortality of mixed infection is higher and increasing with the number of the pathogen types. The prognosis is better in patient who had high leucocyte count and/or low age. Conclusion In patient who had severe basic disease and ever being treated with the third generation eephalosporin, the rate of nosocomial pulmonary infection caused by ESBLs producing Klebsiella pneumoniae is high. Once it was confirmed that such infection did exist, the age, amount of leucocyte, if it was mixed infection, and the type of pathogem were becoming important factors that could affect the patient's prognosis.
机构地区 东莞市人民医院
出处 《现代医院》 2005年第10期15-17,共3页 Modern Hospitals
关键词 肺炎克雷伯菌 ESBLS 院内感染 Klebsiella pneumoniae, ESBLs, Nosocomial infection
  • 相关文献

参考文献5

二级参考文献9

  • 1Liu P Y F,J Amtimicrob Chemother,1992年,30卷,429页
  • 2Pfaller MA, Acar J, Jones RN, et al. Integration of molecular characterization of microorganisms in a global antimicrobial resistance surveillance program[J]. Clin Infect Dis, 2001,15: S156-S167
  • 3National Committee for Clinic Laboratory Standards. Performance standards for antimicrobial susceptibility testing: ninth informational supplement[S]. NCCLS document M100-S9,1999, 19:29-75
  • 4Paterson DL. Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs)[J]. Clin Microbiol Infect, 2000, 6:460-463
  • 5Jacoby GA. Extended-spectrum beta-lactamases and other enzymes providing resistance to oxyimino-β-lactams[J]. Infect Dis Clin North Am, 1997, 11:875-887
  • 6Martinez-Martinez L, Pascual A, Hernandez-Alles S, et al. Roles of beta-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae[J]. Antimicrob Agents Chemother, 1999, 43:1669-1673
  • 7Rebuck JA, Olsen KM, Fey PD, et al. In vitro activities of pa~renteral beta-lactam antimicrobials against TEM-10-, TEM-26- and SHV-5-derived extended-spectrum beta-lactamases expressed in an isogenic Escherichia coli host[J]. J Antimicrob Chemother, 2000, 46:461-464
  • 8Gold HS, Moellering RC Jr. Antimicrobial-drug resistance[J]. N Engl J Med, 1996, 335:1445-1453
  • 9陈亚岗,俞云松,周伟琳,丁永祥,马亦林.浙江省产超广谱β-内酰胺酶大肠埃希菌和肺炎克雷伯菌流行情况及耐药性[J].中华传染病杂志,2000,18(4):236-238. 被引量:51

共引文献141

同被引文献7

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部